Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 797 GBX 0.89%
Market Cap: 1B GBX
Have any thoughts about
Indivior PLC?
Write Note

Indivior PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Indivior PLC
Capital Expenditures Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Indivior PLC
LSE:INDV
Capital Expenditures
-$52m
CAGR 3-Years
-14%
CAGR 5-Years
-24%
CAGR 10-Years
-6%
GlaxoSmithKline PLC
LSE:GSK
Capital Expenditures
-ÂŁ2.3B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
AstraZeneca PLC
LSE:AZN
Capital Expenditures
-$4.1B
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
-3%
Verona Pharma PLC
NASDAQ:VRNA
Capital Expenditures
-$45k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Capital Expenditures
-$205m
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Capital Expenditures
-ÂŁ30.3m
CAGR 3-Years
15%
CAGR 5-Years
-19%
CAGR 10-Years
-13%

See Also

What is Indivior PLC's Capital Expenditures?
Capital Expenditures
-52m USD

Based on the financial report for Jun 30, 2024, Indivior PLC's Capital Expenditures amounts to -52m USD.

What is Indivior PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-6%

Over the last year, the Capital Expenditures growth was -373%. The average annual Capital Expenditures growth rates for Indivior PLC have been -14% over the past three years , -24% over the past five years , and -6% over the past ten years .

Back to Top